Login to Your Account

Clinic Roundup

Tuesday, January 4, 2011
BioLineRx Ltd., of Jerusalem, reported positive results from a Phase I/II trial of BL-5010, a formulation for nonsurgical removal of skin lesions.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription